Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced that at its Annual Meeting of Stockholders held yesterday, Joseph L. Herring and Kurt P. Kuehn were elected to the Company's Board of Directors for one-year terms. These new directors fill vacancies resulting from the retirement of directors Norman S. Matthews and Louis W. Sullivan, M.D.

With these changes, Henry Schein continues to have 15 directors, including 10 independent directors.

"We are extremely fortunate to attract such high-quality directors to our Board. Joseph brings to Henry Scheincomprehensive knowledge of pharmaceuticals, management and sales, and Kurt has extensive experience in distribution logistics, as well as in corporate finance and accounting. We look forward to the contributions both will make to advance the strategic goals of the Company," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein.

Mr. Herring's career in health care spans more than 35 years. He served as CEO of the drug-development services company Covance Inc. for more than a decade, through its acquisition by Laboratory Corporation of America, Inc. (LabCorp) in February 2015. Earlier in his career, he held senior leadership positions with Caremark International and American Hospital Supply Corporation. Mr. Herring currently serves on the nonprofit board for University Medical Center of Princeton and previously served on the board of the Association of Clinical Research Organizations, including as Chairman. As a director of Henry Schein, Mr. Herring will serve on the board's Strategic Advisory Committee.

Mr. Kuehn spent his entire career, which spanned nearly four decades, at United Parcel Service, Inc., (UPS), a global leader in logistics. Most recently, he served as CFO of UPS for eight years, through his retirement in 2015. At UPS, he also held leadership positions in sales and marketing, engineering, operations and strategic cost planning. Mr. Kuehn is also a director at NCR Corporation. As a director of Henry Schein, Mr. Kuehn will serve on the board's Audit Committee.

Mr. Matthews was named a director of Henry Schein in 2002, and has worked as an independent consultant and venture capitalist since 1989. From 1978 to 1988, Mr. Matthews served in various senior management positions for Federated Department Stores, Inc., including president from 1987 to 1988. In 2005, Mr. Matthews was named as one of eight outstanding directors by the Outstanding Directors Exchange (an annual award voted on by peer directors and awarded to an outstanding director for the key role he or she played during a crisis, business transformation or turnaround).

Dr. Sullivan was named a director of Henry Schein in 2003. He is President Emeritus of Morehouse School of Medicine, and from 1989 to 1993, he served as U.S. Secretary of Health and Human Services. Dr. Sullivan served as chair of the President's Commission on Historically Black Colleges and Universities from 2002 to 2009, and was co-chair of the President's Commission on HIV and AIDS from 2001 to 2006. Dr. Sullivan is the founding dean of Morehouse School of Medicine, the founding president of the Association of Minority Health Professions Schools and is a member of the board of numerous charitable organizations. Dr. Sullivan is the recipient of more than 60 honorary degrees.

After retiring from the Company's Board of Directors, it is expected that Mr. Mathews and Dr. Sullivan will continue their relationship with Henry Schein. Mr. Matthews will provide consulting services to the Company on various matters, including marketing, strategy and executive education. Dr. Sullivan will assume the role of Co-Chair of the Henry Schein Cares Foundation, a 501(c)(3) organization that carries out its mission through financial and health care product donations to support health care professionals and community-based programs focused on prevention, wellness, treatment, and education; disaster preparedness and relief; and capacity building of health institutions that provide training and care.

"Norman Matthews and Dr. Sullivan have helped guide Henry Schein through a period of unprecedented growth and change," added Mr. Bergman. "They have been an integral part of Henry Schein's successful journey and have served the Company with integrity and intelligence. On behalf of my colleagues, my fellow directors and our shareholders, I extend our heartfelt thanks to Norm and Lou for their many contributions to Team Schein."

About Henry Schein, Inc. 

Henry Schein, Inc. (Nasdaq: HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein employs nearly 19,000 Team Schein Members and serves more than one million customers.